Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marlise Rachael Luskin, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chen EC, Gandler H, Tošic I, Fell GG, Fiore A, Pozdnyakova O, DeAngelo DJ, Galinsky I, Luskin MR, Wadleigh M, Winer ES, Leonard R, O'Day K, de Jonge A, Neuberg D, Look AT, Stone RM, Frank DA, Garcia JS. Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clin Cancer Res. 2023 Mar 01; 29(5):878-887. PMID: 36534523; PMCID: PMC9992000.
    Citations:    Fields:    Translation:HumansCells
  2. Knoerl R, Mazzola E, Woods H, Buchbinder E, Frazier L, LaCasce A, Luskin MR, Phillips CS, Thornton K, Berry DL, Ligibel J. Exploring Influencing Factors of Anxiety Improvement Following Mindfulness-Based Music Therapy in Young Adults with Cancer. J Music Ther. 2023 Feb 14. PMID: 36787235.
    Citations:    Fields:    
  3. Phillips CS, Bockhoff J, Berry DL, Buchbinder E, Frazier AL, LaCasce A, Ligibel J, Luskin MR, Woods H, Knoerl R. Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic. J Adolesc Young Adult Oncol. 2023 Feb 08. PMID: 36752714.
    Citations:    Fields:    
  4. El-Jawahri A, Luskin MR, Greer JA, Traeger L, Lavoie M, Vaughn DM, Andrews S, Yang D, Boateng KY, Newcomb RA, Ufere NN, Fathi AT, Hobbs G, Brunner A, Abel GA, Stone RM, DeAngelo DJ, Wadleigh M, Temel JS. Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial. Cancer. 2023 Apr 01; 129(7):1075-1084. PMID: 36655338.
    Citations:    Fields:    Translation:Humans
  5. Kimmerling RJ, Stevens MM, Olcum S, Minnah A, Vacha M, LaBella R, Ferri M, Wasserman SC, Fujii J, Shaheen Z, Sundaresan S, Ribadeneyra D, Jayabalan DS, Agte S, Aleman A, Criscitiello JA, Niesvizky R, Luskin MR, Parekh S, Rosenbaum CA, Tamrazi A, Reid CA. Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Commun Biol. 2023 Jan 06; 6(1):15. PMID: 36609595; PMCID: PMC9823002.
    Citations:    
  6. Raman HS, Kim SE, DeAngelo DJ, Stevenson KE, Neuberg D, Winer ES, Wadleigh M, Garcia JS, Kim AS, Stone RM, Ho VT, Luskin MR. Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation. Leuk Res. 2023 02; 125:107004. PMID: 36577290.
    Citations:    Fields:    Translation:HumansCells
  7. Shimony S, Liu Y, Valtis YK, Paolino JD, Place AE, Brunner AM, Weeks LD, Silverman LB, Vrooman LM, Neuberg D, Stone RM, DeAngelo DJ, Luskin MR. Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia. Blood Adv. 2022 Dec 12. PMID: 36508268.
    Citations: 1     Fields:    
  8. Kimmerling RJ, Stevens MM, Olcum S, Minnah A, Vacha M, LaBella R, Ferri M, Wasserman SC, Fujii J, Shaheen Z, Sundaresan S, Ribadeneyra D, Jayabalan DS, Agte S, Aleman A, Criscitiello JA, Niesvizky R, Luskin MR, Parekh S, Rosenbaum CA, Tamrazi A, Reid CA. A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Commun Biol. 2022 11 26; 5(1):1295. PMID: 36435843; PMCID: PMC9701192.
    Citations:    Translation:Humans
  9. Luskin MR. A challenging choice: consolidation in Ph+ ALL. Blood. 2022 11 17; 140(20):2093-2094. PMID: 36394905.
    Citations:    Fields:    
  10. Garcia JS, Flamand Y, Penter L, Keng M, Tomlinson B, Mendez LM, Koller PB, Cullen N, Arihara Y, Pfaff KL, Wolff JO, Brunner AM, Galinsky I, Bashey A, Antin JH, Cutler CS, Ho VT, Jonas BA, Luskin MR, Wadleigh M, Winer ES, Savell A, Leonard R, Robertson T, Davids MS, Streicher H, Rodig SJ, Ritz J, Wu CJ, DeAngelo DJ, Neuberg D, Stone RM, Soiffer RJ. Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings. Blood. 2022 Nov 04. PMID: 36332187.
    Citations: 1     Fields:    
  11. Luskin MR. EXABS-132-ALL Approach to Acute Lymphoblastic Leukemia in The Elderly. Clin Lymphoma Myeloma Leuk. 2022 10; 22 Suppl 2:S34-S38. PMID: 36164013.
    Citations:    Fields:    Translation:Humans
  12. Kayser S, Sartor C, Luskin MR, Webster J, Giglio F, Panitz N, Brunner AM, Fante M, Lutz C, Wolff D, Ho AD, Levis MJ, Schlenk RF, Papayannidis C. Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. Haematologica. 2022 09 01; 107(9):2064-2071. PMID: 35142153; PMCID: PMC9425305.
    Citations:    Fields:    Translation:Humans
  13. Aleissa MM, Gonzalez-Bocco IH, Zekery-Saad S, Kubiak DW, Zhang EM, Signorelli J, Hammond SP, Mohareb AM, Luskin MR, Manne-Goehler J, Marty FM. The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study. Open Forum Infect Dis. 2022 Aug; 9(8):ofac306. PMID: 35949404; PMCID: PMC9356691.
    Citations:    
  14. Teng M, Luskin MR, Cowan-Jacob SW, Ding Q, Fabbro D, Gray NS. The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. J Med Chem. 2022 06 09; 65(11):7581-7594. PMID: 35609336.
    Citations: 4     Fields:    Translation:HumansCells
  15. Versluis J, Pandey M, Flamand Y, Haydu JE, Belizaire R, Faber M, Vedula RS, Charles A, Copson KM, Shimony S, Rozental A, Bendapudi PK, Wolach O, Griffiths EA, Thompson JE, Stone RM, DeAngelo DJ, Neuberg D, Luskin MR, Wang ES, Lindsley RC. Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. Blood Adv. 2022 05 10; 6(9):2835-2846. PMID: 35081257; PMCID: PMC9092400.
    Citations:    Fields:    Translation:Humans
  16. Curran E, Muffly L, Luskin MR. Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age Spectrum. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-11. PMID: 35503981.
    Citations: 1     Fields:    Translation:Humans
  17. Kayser S, Kramer M, Martínez-Cuadrón D, Grenet J, Metzeler KH, Sustkova Z, Luskin MR, Brunner AM, Elliott MA, Gil C, Marini SC, Rácil Z, Cetkovsky P, Novak J, Perl AE, Platzbecker U, Stölzel F, Ho AD, Thiede C, Stone RM, Röllig C, Montesinos P, Schlenk RF, Levis MJ. Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study. Haematologica. 2022 04 01; 107(4):836-843. PMID: 34348451; PMCID: PMC8968900.
    Citations: 3     Fields:    Translation:Humans
  18. Valtis YK, Place AE, Silverman LB, Vrooman LM, DeAngelo DJ, Luskin MR. Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia. Br J Haematol. 2022 08; 198(3):421-430. PMID: 35312041.
    Citations:    Fields:    Translation:Humans
  19. Chen EC, Liu Y, Harris CE, Winer ES, Wadleigh M, Lane AA, Vedula RS, Lindsley RC, Copson KM, Charles A, Marty F, Neuberg D, DeAngelo DJ, Stone RM, Luskin MR, Issa NC, Garcia JS. Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax. Leuk Lymphoma. 2022 08; 63(8):1934-1941. PMID: 35289704; PMCID: PMC9481998.
    Citations: 1     Fields:    Translation:Humans
  20. Schaefer EJ, Wang HC, Karp HQ, Meyer CA, Cejas P, Gearhart MD, Adelman ER, Fares I, Apffel A, Lim K, Xie Y, Gibson CJ, Schenone M, Murdock HM, Wang ES, Gondek LP, Carroll MP, Vedula RS, Winer ES, Garcia JS, Stone RM, Luskin MR, Carr SA, Long HW, Bardwell VJ, Figueroa ME, Lindsley RC. BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes. Blood Cancer Discov. 2022 03 01; 3(2):116-135. PMID: 35015684; PMCID: PMC9414116.
    Citations: 4     Fields:    Translation:HumansCells
  21. Valtis YK, Stevenson KE, Place AE, Silverman LB, Vrooman LM, Gotti G, Brunner AM, Nauffal M, DeAngelo DJ, Luskin MR. Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials. Blood Adv. 2022 01 11; 6(1):72-81. PMID: 34610104; PMCID: PMC8753211.
    Citations: 1     Fields:    Translation:Humans
  22. Mueller SB, Dal Cin P, Le LP, Dias-Santagata D, Lennerz JK, Iafrate AJ, Marble HD, Brunner AM, Weinstock MJ, Luskin MR, De Angelo DJ, Stone RM, Nardi V. t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. Blood Adv. 2022 01 08; 6(3):818-827. PMID: 34587239; PMCID: PMC8945303.
    Citations:    Fields:    Translation:Humans
  23. Van Egeren D, Kamaz B, Liu S, Nguyen M, Reilly CR, Kalyva M, DeAngelo DJ, Galinsky I, Wadleigh M, Winer ES, Luskin MR, Stone RM, Garcia JS, Hobbs GS, Michor F, Cortes-Ciriano I, Mullally A, Hormoz S. Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms. Exp Hematol. 2022 03; 107:14-19. PMID: 34921959; PMCID: PMC9332124.
    Citations:    Fields:    Translation:HumansCells
  24. Luskin MR. SOHO State of the Art Updates and Next Questions: Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future. Clin Lymphoma Myeloma Leuk. 2022 07; 22(7):436-441. PMID: 34996739.
    Citations:    Fields:    Translation:Humans
  25. Luskin MR. Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy? Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):7-14. PMID: 34889389; PMCID: PMC8791151.
    Citations:    Fields:    Translation:Humans
  26. Knoerl R, Mazzola E, Woods H, Buchbinder E, Frazier L, LaCasce A, Li BT, Luskin MR, Phillips CS, Thornton K, Berry DL, Ligibel JA. Exploring the Feasibility of a Mindfulness-Music Therapy Intervention to Improve Anxiety and Stress in Adolescents and Young Adults with Cancer. J Pain Symptom Manage. 2022 Apr; 63(4):e357-e363. PMID: 34896280.
    Citations:    Fields:    Translation:Humans
  27. Chen SX, Lopez CG, Kassamali B, Luskin MR, Charrow A. Hidradenitis suppurativa in acute myeloid leukemia: Review of disease course and management. JAAD Case Rep. 2022 Jan; 19:44-47. PMID: 34917723.
    Citations:    
  28. Hantel A, Luskin MR, Garcia JS, Stock W, DeAngelo DJ, Abel GA. Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. Blood Adv. 2021 11 09; 5(21):4352-4360. PMID: 34473244.
    Citations: 3     Fields:    Translation:Humans
  29. Tsai FD, Guercio B, Stuver S, Stern R, Peluso MJ, Winkler M, Piawah S, Vallurupalli M, Luskin MR, Braun D, Parent A, Glotzbecker B, Kilbridge KL. Resident-Reported Impact of a Novel Oncology Curriculum for Internal Medicine Residents. J Cancer Educ. 2022 12; 37(6):1879-1885. PMID: 34480712; PMCID: PMC8417651.
    Citations:    Fields:    Translation:Humans
  30. Aleissa MM, Alshehri BS, Gonzalez-Bocco IH, McDonnell AM, Leblebjian H, Marty FM, Luskin MR. Triazole antifungal use for prophylaxis and treatment of invasive fungal diseases for patients receiving gilteritinib. Leuk Res. 2021 09; 108:106610. PMID: 34048999.
    Citations: 1     Fields:    Translation:Humans
  31. Manzano GS, Torre M, Luskin MR, Vaitkevicius H. Clinical Reasoning: A 59-Year-Old Woman Presenting With Diplopia, Dysarthria, Right-Sided Weakness, and Encephalopathy. Neurology. 2021 08 24; 97(8):e859-e864. PMID: 33947777; PMCID: PMC9245924.
    Citations:    Fields:    Translation:Humans
  32. Wang D, He K, Sroussi H, Treister N, Luskin M, Villa A, Woo SB, Shazib MA. Oral myeloid sarcoma as an uncommon manifestation of acute myeloid leukemia: A case series and review of the literature. J Am Dent Assoc. 2021 May; 152(5):393-400.e8. PMID: 33926625.
    Citations: 1     Fields:    Translation:Humans
  33. Haydu JE, Flamand Y, Vedula RS, Versluis J, Charles A, Copson KM, Stone RM, DeAngelo DJ, Neuberg D, Lindsley RC, Luskin MR. Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction. Am J Hematol. 2021 07 01; 96(7):E259-E262. PMID: 33837971; PMCID: PMC8589075.
    Citations: 1     Fields:    Translation:Humans
  34. Chen EC, Li S, Eisfeld AK, Luskin MR, Mims A, Jones D, Antin JH, Cutler CS, Koreth J, Ho VT, Gooptu M, Romee R, El-Jawahri A, McAfee SL, DeFilipp Z, Soiffer RJ, Chen YB, Fathi AT. Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 06; 27(6):479.e1-479.e7. PMID: 33840625.
    Citations: 5     Fields:    Translation:Humans
  35. Van Egeren D, Escabi J, Nguyen M, Liu S, Reilly CR, Patel S, Kamaz B, Kalyva M, DeAngelo DJ, Galinsky I, Wadleigh M, Winer ES, Luskin MR, Stone RM, Garcia JS, Hobbs GS, Camargo FD, Michor F, Mullally A, Cortes-Ciriano I, Hormoz S. Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms. Cell Stem Cell. 2021 03 04; 28(3):514-523.e9. PMID: 33621486; PMCID: PMC7939520.
    Citations: 49     Fields:    Translation:HumansCells
  36. Raman HS, Shanmugam V, Li J, Steensma DP, Kim AS, Luskin MR. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation. Leuk Lymphoma. 2021 07; 62(7):1790-1792. PMID: 33586600.
    Citations:    Fields:    Translation:Humans
  37. Hantel A, DuMontier C, Odejide OO, Luskin MR, Sperling AS, Hshieh T, Chen R, Soiffer R, Driver JA, Abel GA. Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Cancer. 2021 03 15; 127(6):875-883. PMID: 33237587; PMCID: PMC7946649.
    Citations: 1     Fields:    Translation:Humans
  38. Luskin MR, DeAngelo DJ. Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S44-S47. PMID: 32862865.
    Citations: 2     Fields:    Translation:Humans
  39. Luskin MR, Kim AS, Patel SS, Wright K, LeBoeuf NR, Lane AA. Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone. Leuk Lymphoma. 2020 09; 61(9):2258-2261. PMID: 32366145.
    Citations: 3     Fields:    Translation:HumansCells
  40. Brunner AM, Blonquist TM, DeAngelo DJ, McMasters M, Fell G, Hermance NM, Winer ES, Lindsley RC, Hobbs GS, Amrein PC, Hock HR, Steensma DP, Garcia JS, Luskin MR, Stone RM, Ballen KK, Rosenblatt J, Avigan D, Nahas MR, Mendez LM, McAfee SL, Moran JA, Bergeron M, Foster J, Bertoli C, Manning AL, McGregor KL, Fishman KM, Kuo FC, Baltay MT, Macrae M, Burke M, Behnan T, Wey MC, Som TT, Ramos AY, Rae J, Lombardi Story J, Nelson N, Logan E, Connolly C, Neuberg DS, Chen YB, Graubert TA, Fathi AT. Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial. Lancet Haematol. 2020 Feb; 7(2):e122-e133. PMID: 31837959.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  41. Hathorn KE, Luskin MR, Caton MT, DeAngelo DJ, Saltzman JR. Colonic Wall Thickening as the First Indicator of Relapse of Acute Lymphoblastic Leukemia. ACG Case Rep J. 2019 Aug; 6(8):e00207. PMID: 31737733; PMCID: PMC6791643.
    Citations:    
  42. Zhang H, Wilmot B, Bottomly D, Dao KT, Stevens E, Eide CA, Khanna V, Rofelty A, Savage S, Reister Schultz A, Long N, White L, Carlos A, Henson R, Lin C, Searles R, Collins RH, DeAngelo DJ, Deininger MW, Dunn T, Hein T, Luskin MR, Medeiros BC, Oh ST, Pollyea DA, Steensma DP, Stone RM, Druker BJ, McWeeney SK, Maxson JE, Gotlib JR, Tyner JW. Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. Blood. 2019 09 12; 134(11):867-879. PMID: 31366621; PMCID: PMC6742922.
    Citations: 19     Fields:    Translation:HumansCells
  43. Kayser S, Hills RK, Luskin MR, Brunner AM, Terré C, Westermann J, Menghrajani K, Shaw C, Baer MR, Elliott MA, Perl AE, Rácil Z, Mayer J, Zak P, Szotkowski T, de Botton S, Grimwade D, Mayer K, Walter RB, Krämer A, Burnett AK, Ho AD, Platzbecker U, Thiede C, Ehninger G, Stone RM, Röllig C, Tallman MS, Estey EH, Müller-Tidow C, Russell NH, Schlenk RF, Levis MJ. Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study. Haematologica. 2020 01; 105(1):161-169. PMID: 31004014.
    Citations: 5     Fields:    Translation:Humans
  44. Stern RM, Luskin MR, Clark RP, Miller AL, Loscalzo J. A Headache of a Diagnosis. N Engl J Med. 2018 Aug 02; 379(5):475-479. PMID: 30067932.
    Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  45. Luskin MR. Chronic myeloid leukemia and pregnancy: patient and partner perspectives. Expert Rev Hematol. 2018 08; 11(8):597-599. PMID: 30012034.
    Citations: 4     Fields:    Translation:Humans
  46. Luskin MR, DeAngelo DJ. How to treat chronic myeloid leukemia (CML) in older adults. J Geriatr Oncol. 2018 07; 9(4):291-295. PMID: 29463446.
    Citations:    Fields:    Translation:Humans
  47. Luskin MR, Murakami MA, Manalis SR, Weinstock DM. Targeting minimal residual disease: a path to cure? Nat Rev Cancer. 2018 04; 18(4):255-263. PMID: 29376520; PMCID: PMC6398166.
    Citations: 42     Fields:    Translation:Humans
  48. Luskin MR, Abel GA. Management of older adults with myelodysplastic syndromes (MDS). J Geriatr Oncol. 2018 07; 9(4):302-307. PMID: 29290596.
    Citations: 1     Fields:    Translation:Humans
  49. Banerjee R, Luskin MR, Loren AW. Late effects of blood and marrow transplantation. Haematologica. 2017 11; 102(11):e465. PMID: 29079647.
    Citations:    Fields:    Translation:Humans
  50. Luskin MR, DeAngelo DJ. Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia. Expert Rev Hematol. 2017 12; 10(12):1033-1045. PMID: 29069942.
    Citations: 6     Fields:    Translation:Humans
  51. Luskin MR, Discenza MN, Easter SR, Dal Cin P, Owen R, Ilagan B, Masiello M, Lane AA. Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening. Blood Adv. 2017 Aug 22; 1(19):1491-1494. PMID: 29296790.
    Citations: 3     Fields:    
  52. Luskin MR, Stone RM. Can Minimal Residual Disease Determination in Acute Myeloid Leukemia Be Used in Clinical Practice? J Oncol Pract. 2017 08; 13(8):471-480. PMID: 28796964.
    Citations: 5     Fields:    Translation:Humans
  53. Luskin MR, DeAngelo DJ. Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice. Curr Hematol Malig Rep. 2017 08; 12(4):370-379. PMID: 28656487.
    Citations: 9     Fields:    Translation:HumansCells
  54. Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017 08 31; 130(9):1156-1164. PMID: 28674027; PMCID: PMC5580273.
    Citations: 69     Fields:    Translation:Humans
  55. Honigberg MC, Eshel N, Luskin MR, Shaykevich S, Lipsitz SR, Katz JT. Curricular Time, Patient Exposure, and Comfort Caring for Lesbian, Gay, Bisexual, and Transgender Patients Among Recent Medical Graduates. LGBT Health. 2017 06; 4(3):237-239. PMID: 28418736.
    Citations: 9     Fields:    Translation:Humans
  56. Luskin MR, Cronin AM, Owens RL, DeAngelo DJ, Stone RM, Wadleigh M, Steensma DP, Abel GA. Self-reported sleep disturbance and survival in myelodysplastic syndromes. Br J Haematol. 2017 05; 177(4):562-566. PMID: 28272741.
    Citations: 3     Fields:    Translation:Humans
  57. Dinardo CD, Luskin MR, Carroll M, Smith C, Harrison J, Pierce S, Kornblau S, Konopleva M, Kadia T, Kantarjian H, Wertheim GB, Master SR. Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML. Am J Hematol. 2017 Feb; 92(2):E14-E15. PMID: 27804182; PMCID: PMC5915352.
    Citations: 5     Fields:    Translation:HumansCells
  58. Wertheim GBW, Luskin MR, Carroll M, Master SR. Microsphere-Based Assessment of DNA Methylation for AML Prognosis. Methods Mol Biol. 2017; 1633:125-136. PMID: 28735484.
    Citations:    Fields:    Translation:HumansCells
  59. Luskin MR, Carroll M, Lieberman D, Morrissette JJD, Zhao J, Crisalli L, Roth DB, Luger SM, Porter DL, Reshef R. Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 11; 22(11):1961-1967. PMID: 27478011; PMCID: PMC5067228.
    Citations: 15     Fields:    Translation:Humans
  60. Luskin MR, Gimotty PA, Smith C, Loren AW, Figueroa ME, Harrison J, Sun Z, Tallman MS, Paietta EM, Litzow MR, Melnick AM, Levine RL, Fernandez HF, Luger SM, Carroll M, Master SR, Wertheim GB. A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia. JCI Insight. 2016 Jun 16; 1(9). PMID: 27446991.
    Citations: 9     Fields:    
  61. Sloan CE, Luskin MR, Boccuti AM, Sehgal AR, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Gimotty PA, Carroll M. A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia. PLoS One. 2016; 11(4):e0153016. PMID: 27050425; PMCID: PMC4822876.
    Citations: 6     Fields:    Translation:Humans
  62. Luskin MR, Lee JW, Fernandez HF, Abdel-Wahab O, Bennett JM, Ketterling RP, Lazarus HM, Levine RL, Litzow MR, Paietta EM, Patel JP, Racevskis J, Rowe JM, Tallman MS, Sun Z, Luger SM. Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood. 2016 Mar 24; 127(12):1551-8. PMID: 26755712; PMCID: PMC4807422.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  63. Aikawa V, Porter D, Luskin MR, Bagg A, Morrissette JJ. Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm. Cancer Genet. 2015 Dec; 208(12):625-9. PMID: 26628205.
    Citations: 3     Fields:    Translation:Humans
  64. Luskin MR, Ganetsky A, Landsburg DJ, Loren AW, Porter DL, Nasta SD, Svoboda J, Luger SM, Frey NV. Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma. Br J Haematol. 2016 07; 174(2):332-4. PMID: 26403537.
    Citations: 5     Fields:    Translation:Humans
  65. Luskin MR, Banerjee R, Del Percio S, Loren AW. A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies. Curr Hematol Malig Rep. 2015 Sep; 10(3):225-36. PMID: 26162948.
    Citations: 1     Fields:    Translation:Humans
  66. Luskin MR, Huen AO, Brooks SA, Stewart C, Watt CD, Morrissette JJ, Lieberman DB, Bagg A, Rosenbach M, Perl AE. NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features. Haematologica. 2015 Oct; 100(10):e412-4. PMID: 26113416; PMCID: PMC4591778.
    Citations: 5     Fields:    Translation:HumansCells
  67. Reshef R, Huffman AP, Gao A, Luskin MR, Frey NV, Gill SI, Hexner EO, Kambayashi T, Loren AW, Luger SM, Mangan JK, Nasta SD, Richman LP, Sell M, Stadtmauer EA, Vonderheide RH, Mick R, Porter DL. High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning. J Clin Oncol. 2015 Jul 20; 33(21):2392-8. PMID: 26056179; PMCID: PMC4500833.
    Citations: 21     Fields:    Translation:HumansCells
  68. Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R. The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. Am J Transplant. 2015 Oct; 15(10):2665-73. PMID: 25988622; PMCID: PMC5726526.
    Citations: 44     Fields:    Translation:Humans
  69. Tsai DE, Luskin MR, Kremer BE, Chung AK, Arnoldi S, Paralkar VR, Nasta SD, Stadtmauer EA, Schuster SJ, Xavier M. A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types. Leuk Lymphoma. 2015 May; 56(5):1530-2. PMID: 25219594.
    Citations: 6     Fields:    Translation:HumansCells
  70. Wertheim GB, Smith C, Luskin M, Rager A, Figueroa ME, Carroll M, Master SR. Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP. Clin Chem. 2015 Jan; 61(1):249-58. PMID: 25348669; PMCID: PMC4384518.
    Citations: 5     Fields:    Translation:HumansCells
  71. Frosch Z, Luskin MR, Landsburg DJ, Schuster SJ, Svoboda J, Loren AW, Porter DL, Stadtmauer EA, Nasta SD. R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Clin Lymphoma Myeloma Leuk. 2015 Feb; 15(2):92-7. PMID: 25174772.
    Citations: 6     Fields:    Translation:Humans
  72. Luskin M, Wertheim G, Morrissette J, Daber R, Biegel J, Wilmoth D, Kersun L, King R, Paessler M, Simon C, Aplenc R, Loren A. CLL/SLL diagnosed in an adolescent. Pediatr Blood Cancer. 2014 Jun; 61(6):1107-10. PMID: 24281971.
    Citations: 2     Fields:    Translation:HumansCells
  73. Luskin MR, Roy DB, Wasik MA, Loren AW. Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimen. Clin Lymphoma Myeloma Leuk. 2014 Apr; 14(2):e55-8. PMID: 24393621.
    Citations: 3     Fields:    Translation:HumansCells
  74. Luskin MR, Campigotto F, Richardson PG, Koreth J, Ghobrial IM, Schlossman RL, Munshi NC, Alyea EP, Soiffer RJ, Warren D, Gannon M, Finn K, Anderson KC, Weller EA, Laubach JP. The impact of ASCT on patients with newly diagnosed multiple myeloma who receive RVD induction. Journal of Hematological Malignancies. 2013; 1(3):41-48. View Publication.
  75. Laubach JP, Mitsiades CS, Mahindra A, Luskin MR, Rosenblatt J, Ghobrial IM, Schlossman RL, Avigan D, Raje N, Munshi NC, Anderson KC, Richardson PG. Management of relapsed and relapsed/refractory multiple myeloma. J Natl Compr Canc Netw. 2011 Oct; 9(10):1209-16. PMID: 21975917.
    Citations: 12     Fields:    Translation:Humans
  76. Reshef R, Luskin MR, Kamoun M, Vardhanabhuti S, Tomaszewski JE, Stadtmauer EA, Porter DL, Heitjan DF, Tsai de E. Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. Am J Transplant. 2011 Apr; 11(4):817-25. PMID: 21401872; PMCID: PMC3072270.
    Citations: 18     Fields:    Translation:Humans
  77. Reshef R, Vardhanabhuti S, Luskin MR, Heitjan DF, Hadjiliadis D, Goral S, Krok KL, Goldberg LR, Porter DL, Stadtmauer EA, Tsai DE. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(?). Am J Transplant. 2011 Feb; 11(2):336-47. PMID: 21219573; PMCID: PMC3079420.
    Citations: 61     Fields:    Translation:Humans
  78. Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT, Kottilil S, Lifson JD, Metcalf JA, Lempicki RA, Connors M. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. 2008 Apr; 82(8):3997-4006. PMID: 18256146.
    Citations: 53     Fields:    Translation:HumansCells
  79. Tilton JC, Luskin MR, Johnson AJ, Manion M, Hallahan CW, Metcalf JA, McLaughlin M, Davey RT, Connors M. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J Virol. 2007 Mar; 81(6):2713-25. PMID: 17182676; PMCID: PMC1865970.
    Citations: 40     Fields:    Translation:HumansCells
  80. Tilton JC, Johnson AJ, Luskin MR, Manion MM, Yang J, Adelsberger JW, Lempicki RA, Hallahan CW, McLaughlin M, Mican JM, Metcalf JA, Iyasere C, Connors M. Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol. 2006 Dec; 80(23):11486-97. PMID: 17005663; PMCID: PMC1642603.
    Citations: 44     Fields:    Translation:HumansCells
  81. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005 Sep; 37(3):248-51. PMID: 16109349.
    Citations: 50     Fields:    Translation:HumansCellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Luskin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (285)
Explore
_
Co-Authors (119)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.